Works matching IS 13518216 AND DT 2022 AND VI 28 AND IP 5
Results: 34
First case report on persistent patellar dislocation in haemophilia A patient with a factor VIII inhibitor.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e113, doi. 10.1111/hae.14606
- By:
- Publication type:
- Article
Which part of the blood in the knee joint is responsible for its detrimental effects? (An experimental study on the knee joint in rabbits).
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 865, doi. 10.1111/hae.14605
- By:
- Publication type:
- Article
The long‐term clinical benefits and economic costs associated with increased use of prophylaxis among patients with haemophilia A in China: Population‐based predictions from 2018 to 2033.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 726, doi. 10.1111/hae.14603
- By:
- Publication type:
- Article
Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 737, doi. 10.1111/hae.14589
- By:
- Publication type:
- Article
Building the blueprint: Formulating a community‐generated national plan for future research in inherited bleeding disorders.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 760, doi. 10.1111/hae.14588
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. i, doi. 10.1111/hae.14634
- Publication type:
- Article
In vitro evaluation of global coagulation potentials in the co‐presence of plasma‐derived factors Viia/X products (Byclot<sup>®</sup>) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e149, doi. 10.1111/hae.14650
- By:
- Publication type:
- Article
Immune checkpoint inhibitor‐induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e145, doi. 10.1111/hae.14632
- By:
- Publication type:
- Article
Real‐world data on emicizumab prophylaxis in the Milan cohort.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e141, doi. 10.1111/hae.14630
- By:
- Publication type:
- Article
UK haemophilia consultant access to foot and ankle services and concurrent patient impact questionnaire responses to foot and ankle interventions.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e136, doi. 10.1111/hae.14625
- By:
- Publication type:
- Article
Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8 Mb deletion encompassing the entire fibrinogen gene cluster.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e132, doi. 10.1111/hae.14621
- By:
- Publication type:
- Article
Health‐related quality of life and associated factors: Results from the haemophilia QOL questionnaire for adults (Haem‐A‐QOL) in a low‐income country with public policies to improve haemophilia care.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e125, doi. 10.1111/hae.14618
- By:
- Publication type:
- Article
World federation of hemophilia international hemophilia training fellowship program: 50 years of enhancing global care.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. S129, doi. 10.1111/hae.14617
- By:
- Publication type:
- Article
Relationship between bleeding episodes, health‐related quality of life and direct costs in adults with severe haemophilia A: Secondary analyses from the CHESS study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e117, doi. 10.1111/hae.14616
- By:
- Publication type:
- Article
Health‐related quality of life among adults with haemophilia in China: A comparison with age‐matched general population.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 776, doi. 10.1111/hae.14615
- By:
- Publication type:
- Article
Autoimmune acquired factor XIII deficiency in Japan 2021 update: Focused on annual incidence and clinical features.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e121, doi. 10.1111/hae.14613
- By:
- Publication type:
- Article
Post‐procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 806, doi. 10.1111/hae.14609
- By:
- Publication type:
- Article
The GOAL‐Hēm journey: Shared decision making and patient‐centred outcomes.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 784, doi. 10.1111/hae.14608
- By:
- Publication type:
- Article
Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct‐acting antiviral agents: A national inpatient sample study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 769, doi. 10.1111/hae.14607
- By:
- Publication type:
- Article
Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2).
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 745, doi. 10.1111/hae.14602
- By:
- Publication type:
- Article
The legacy of haemophilia: Memories and reflections from three survivors.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 872, doi. 10.1111/hae.14587
- By:
- Publication type:
- Article
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 694, doi. 10.1111/hae.14581
- By:
- Publication type:
- Article
Patient‐derived assessment tool using musculoskeletal ultrasound for validation of haemarthrosis.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 842, doi. 10.1111/hae.14591
- By:
- Publication type:
- Article
Befovacimab, an anti‐tissue factor pathway inhibitor antibody: Early termination of the multiple‐dose, dose‐escalating Phase 2 study due to thrombosis.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 702, doi. 10.1111/hae.14595
- By:
- Publication type:
- Article
Determining the incidence of postpartum haemorrhage among Ontario women with and without inherited bleeding disorders: A population‐based cohort study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 832, doi. 10.1111/hae.14594
- By:
- Publication type:
- Article
Endothelial specific isoform of type XVIII collagen (COL‐18N): A marker of vascular integrity in haemophilic arthropathy.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 849, doi. 10.1111/hae.14593
- By:
- Publication type:
- Article
LongHest project: A prospective, observational study of extended half‐life treatment in the musculoskeletal health of patients with severe haemophilia A.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 857, doi. 10.1111/hae.14592
- By:
- Publication type:
- Article
Safety of intramuscular COVID‐19 vaccination in patients with haemophilia.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 687, doi. 10.1111/hae.14586
- By:
- Publication type:
- Article
Examining the impact of haemophilia treatment on health‐related quality of life.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 796, doi. 10.1111/hae.14583
- By:
- Publication type:
- Article
Pharmacokinetic profile of children with haemophilia A receiving low‐dose FVIII prophylaxis in Indonesia: A single centre experience.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 720, doi. 10.1111/hae.14584
- By:
- Publication type:
- Article
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 814, doi. 10.1111/hae.14582
- By:
- Publication type:
- Article
Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 713, doi. 10.1111/hae.14585
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. i, doi. 10.1111/hae.14634
- Publication type:
- Article
Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 822, doi. 10.1111/hae.14579
- By:
- Publication type:
- Article